Obesity affects how patients experience and respond to acute respiratory distress syndrome (ARDS), but not always in predictable ways. While excess weight is typically linked with worse lung function and chronic inflammation, some data suggest that moderately obese patients might actually survive ARDS more often than those with normal weight—a puzzling phenomenon often called the “obesity paradox.” Still, this idea remains debated, and it’s possible that factors like earlier ICU admission or differences in comorbidities play a role. At the biological level, things get more complicated. Adipose tissue isn’t just fat storage—it also behaves like an endocrine organ, producing both inflammatory and anti-inflammatory signals. In obesity, this balance is disrupted. There’s more TNF-α and IL-6 and less adiponectin, which pushes the immune system toward a more inflammatory profile. This includes a shift in macrophages and impaired neutrophil activity, which may worsen lung injury, especially during a cytokine storm. Obesity also complicates mechanical ventilation. High pleural pressures, reduced lung volumes, and airway closure make it harder to ventilate these patients effectively. Strategies like higher positive end-expiratory pressure (PEEP) and recruitment maneuvers can help but must be applied carefully to avoid side effects. Understanding how obesity changes the pathophysiology of ARDS—both at the bedside and in the immune system—is key to tailoring better therapies.